FDA Drug · D-0039-2027

Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1907-1.

Class II · Ongoing

Failed Impurities/Degradation Specifications.

Advertisement
Advertisement
Affected lots / codes — check yours against thisLot #: LB00047A, LB00048A, Exp. Date 03/2028
Recalling firm
Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
Classification
Class II (temporary or reversible harm possible)
Status
Ongoing
Quantity
70776 vials
Distribution
Nationwide within the United States
Recall initiated
October 1, 2026
Classified
October 13, 2026
Initiation
Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0039-2027%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →